国际妇产科联盟（FIGO）修订的妇科癌症分期 - Suppr

Suppr

超能文献

Revised FIGO staging for gynaecological cancer.

作者信息

Shepherd J H

机构信息

St Bartholomew's Hospital, London.

出版信息

Br J Obstet Gynaecol. 1989 Aug;96(8):889-92. doi: 10.1111/j.1471-0528.1989.tb03341.x.

DOI:10.1111/j.1471-0528.1989.tb03341.x

PMID:2775686

Abstract

摘要

相似文献

Revised FIGO staging for gynaecological cancer.

Br J Obstet Gynaecol. 1989 Aug;96(8):889-92. doi: 10.1111/j.1471-0528.1989.tb03341.x.

Gynaecological cancer--is current staging practice outmoded?

Aust N Z J Obstet Gynaecol. 1984 May;24(2):147-9. doi: 10.1111/j.1479-828x.1984.tb01477.x.

[Proposal for the modification of the TNM of gynecological neoplasms].

Minerva Ginecol. 1987 Apr;39(4):229-36.

Classification and staging of gynecologic malignancies. ACOG Technical Bulletin Number 155--May 1991 (replaces No. 47, June 1977).

Int J Gynaecol Obstet. 1992 Aug;38(4):319-23.

Microinvasive carcinoma in gynaecological pathology.

Clin Obstet Gynaecol. 1984 Apr;11(1):239-57.

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.

Int J Gynaecol Obstet. 2000 Aug;70(2):209-62.

New gynecologic cancer staging.

Obstet Gynecol. 1990 Feb;75(2):287-8.

Prognostic factors in gynecologic cancers.

Curr Opin Oncol. 1989 Oct;1(1):82-8. doi: 10.1097/00001622-198910000-00024.

Surgical staging of gynecologic malignancies.

Cancer. 1987 Oct 15;60(8 Suppl):2010-20. doi: 10.1002/1097-0142(19901015)60:8+<2010::aid-cncr2820601512>3.0.co;2-y.

[Summary of the Third National Conference on Gynecological Pathology].

Zhonghua Fu Chan Ke Za Zhi. 1993 Apr;28(4):198-201.

引用本文的文献

Research progress of ECT2 and RhoA-related signaling pathways in gynecological tumors.

Front Cell Dev Biol. 2025 Jun 27;13:1602649. doi: 10.3389/fcell.2025.1602649. eCollection 2025.

The past, present, and future of FIGO staging of endometrial cancer.

J Gynecol Oncol. 2025 Jul;36(4):e105. doi: 10.3802/jgo.2025.36.e105. Epub 2025 Apr 14.

Primary or Interval Debulking Surgery for Advanced Endometrial Cancer with Carcinosis: A Systematic Review and Individual Patient Data Meta-Analysis of Survival Outcomes.

Cancers (Basel). 2025 Mar 19;17(6):1026. doi: 10.3390/cancers17061026.

Prognostic significance of para-aortic node metastasis in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis.

J Gynecol Oncol. 2025 Jul;36(4):e57. doi: 10.3802/jgo.2025.36.e57. Epub 2025 Jan 29.

Challenging the Binary Classification of Endometrioid Endometrial Adenocarcinoma: The Evaluation of Grade 2 as an Independent Entity Based on Prognostic Characteristics and Recurrence Patterns.

Cancers (Basel). 2025 Jan 3;17(1):127. doi: 10.3390/cancers17010127.

An antibody-drug conjugate for endometrioid carcinoma based on the expression of cell adhesion molecule 1.

Mol Cell Oncol. 2024 Sep 5;11(1):2399379. doi: 10.1080/23723556.2024.2399379. eCollection 2024.

Prognostic Factors in Uterine Sarcoma Based on the Tumor Size Stratification: A Retrospective Study.

Cureus. 2024 Jul 31;16(7):e65819. doi: 10.7759/cureus.65819. eCollection 2024 Jul.

2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both.

Int J Gynecol Cancer. 2024 Oct 7;34(10):1580-1587. doi: 10.1136/ijgc-2024-005567.

Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis.

J Gynecol Oncol. 2025 Jan;36(1):e3. doi: 10.3802/jgo.2025.36.e3. Epub 2024 Jun 3.

Laparoscopic surgery for endometrial cancer is oncologically safe and improves hospital stay duration: a retrospective single-center study over a 16-year period.

Arch Gynecol Obstet. 2024 Aug;310(2):1207-1213. doi: 10.1007/s00404-024-07550-x. Epub 2024 May 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Revised FIGO staging for gynaecological cancer.

作者信息

Shepherd J H

机构信息

St Bartholomew's Hospital, London.

出版信息

Br J Obstet Gynaecol. 1989 Aug;96(8):889-92. doi: 10.1111/j.1471-0528.1989.tb03341.x.

DOI:10.1111/j.1471-0528.1989.tb03341.x

PMID:2775686

Abstract

摘要

相似文献

Revised FIGO staging for gynaecological cancer.

Br J Obstet Gynaecol. 1989 Aug;96(8):889-92. doi: 10.1111/j.1471-0528.1989.tb03341.x.

Gynaecological cancer--is current staging practice outmoded?

Aust N Z J Obstet Gynaecol. 1984 May;24(2):147-9. doi: 10.1111/j.1479-828x.1984.tb01477.x.

[Proposal for the modification of the TNM of gynecological neoplasms].

Minerva Ginecol. 1987 Apr;39(4):229-36.

Classification and staging of gynecologic malignancies. ACOG Technical Bulletin Number 155--May 1991 (replaces No. 47, June 1977).

Int J Gynaecol Obstet. 1992 Aug;38(4):319-23.

Microinvasive carcinoma in gynaecological pathology.

Clin Obstet Gynaecol. 1984 Apr;11(1):239-57.

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.

Int J Gynaecol Obstet. 2000 Aug;70(2):209-62.

New gynecologic cancer staging.

Obstet Gynecol. 1990 Feb;75(2):287-8.

Prognostic factors in gynecologic cancers.

Curr Opin Oncol. 1989 Oct;1(1):82-8. doi: 10.1097/00001622-198910000-00024.

Surgical staging of gynecologic malignancies.

Cancer. 1987 Oct 15;60(8 Suppl):2010-20. doi: 10.1002/1097-0142(19901015)60:8+<2010::aid-cncr2820601512>3.0.co;2-y.

[Summary of the Third National Conference on Gynecological Pathology].

Zhonghua Fu Chan Ke Za Zhi. 1993 Apr;28(4):198-201.

引用本文的文献

Research progress of ECT2 and RhoA-related signaling pathways in gynecological tumors.

Front Cell Dev Biol. 2025 Jun 27;13:1602649. doi: 10.3389/fcell.2025.1602649. eCollection 2025.

The past, present, and future of FIGO staging of endometrial cancer.

J Gynecol Oncol. 2025 Jul;36(4):e105. doi: 10.3802/jgo.2025.36.e105. Epub 2025 Apr 14.

Primary or Interval Debulking Surgery for Advanced Endometrial Cancer with Carcinosis: A Systematic Review and Individual Patient Data Meta-Analysis of Survival Outcomes.

Cancers (Basel). 2025 Mar 19;17(6):1026. doi: 10.3390/cancers17061026.

Prognostic significance of para-aortic node metastasis in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis.

J Gynecol Oncol. 2025 Jul;36(4):e57. doi: 10.3802/jgo.2025.36.e57. Epub 2025 Jan 29.

Challenging the Binary Classification of Endometrioid Endometrial Adenocarcinoma: The Evaluation of Grade 2 as an Independent Entity Based on Prognostic Characteristics and Recurrence Patterns.

Cancers (Basel). 2025 Jan 3;17(1):127. doi: 10.3390/cancers17010127.

An antibody-drug conjugate for endometrioid carcinoma based on the expression of cell adhesion molecule 1.

Mol Cell Oncol. 2024 Sep 5;11(1):2399379. doi: 10.1080/23723556.2024.2399379. eCollection 2024.

Prognostic Factors in Uterine Sarcoma Based on the Tumor Size Stratification: A Retrospective Study.

Cureus. 2024 Jul 31;16(7):e65819. doi: 10.7759/cureus.65819. eCollection 2024 Jul.

2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both.

Int J Gynecol Cancer. 2024 Oct 7;34(10):1580-1587. doi: 10.1136/ijgc-2024-005567.

Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis.

J Gynecol Oncol. 2025 Jan;36(1):e3. doi: 10.3802/jgo.2025.36.e3. Epub 2024 Jun 3.

Laparoscopic surgery for endometrial cancer is oncologically safe and improves hospital stay duration: a retrospective single-center study over a 16-year period.

Arch Gynecol Obstet. 2024 Aug;310(2):1207-1213. doi: 10.1007/s00404-024-07550-x. Epub 2024 May 25.